BridgeMD
Tests treatment safety and results for Bone Loss
Official title The Effectiveness in the Treatment of Long Bone Defect Using 3D-printed Implant
ClinicalTrials.gov ID: NCT04449211
What this study is testing
- What it's testing
- To evaluate the effectiveness of 3D-printed titanium alloy implants in the treatment of long bone defect in adults
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult participants with health insurance regardless of sex having bone defect greater than 5cm due to trauma or tumour resection agree to participate...
You likely can't join if
- Participants with contraindication to surgery
- Participants do not agree to undergo surgery
- Participants with local infection or soft tissue defect
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.